KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search   
        Click to View ALL BNF
 >>  >> 
   (Click to View Drug List)


Cost
Packs
Items
Other - Cost: £689,192,594.20 Atorvastatin - Cost: £10,466,720.34 Apixaban - Cost: £10,846,868.70 Empagliflozin (Jardiance) - Cost: £12,651,429.92 Beclometasone / Formoterol MDI (Fostair) - Cost: £14,988,296.04 FreeStyle Libre 2 Sensor  - Cost: £18,184,600.00 Rivaroxaban - Cost: £18,923,630.40 Edoxaban (Lixiana) - Cost: £20,135,410.75 Dapagliflozin (Forxiga) - Cost: £21,502,318.54
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Sub Paragraph)
NICE Guidance (10)
Other Links (5)
Important Local Documents (6)

Cornwall Joint Formulary Recommended Choices     (...Top)
Displaying 9 Drugs

Key:
First Line Drugs First Line Drugs
Second Line Drugs Second Line Drugs
Specialist Initiated Drugs Specialist Initiated Drugs
Hospital Only Drugs Hospital Only Drugs
Discouraged Discouraged
No comment available No comment available
Antibiotics Antibiotics

NameTariffBNF Sub Paragraph
Nicorandil
10 mg tab Pack of 60
£1.74PCT FORMULARY STATUS: Specialist Initiated Drugs Other Antianginal DrugsView BNF Article on 'Nicorandil'View SPC on 'Nicorandil'View PIL on 'Nicorandil'
Nicorandil
20 mg tab Pack of 60
£2.38PCT FORMULARY STATUS: Specialist Initiated Drugs Other Antianginal DrugsView BNF Article on 'Nicorandil'View SPC on 'Nicorandil'View PIL on 'Nicorandil'
Ivabradine
7.5 mg tablets Pack of 56
£3.82PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Can be initiated in primary care following specialist recommendation  Other Antianginal DrugsView BNF Article on 'Ivabradine'View SPC on 'Ivabradine'View PIL on 'Ivabradine'
Can be initiated in primary care following specialist recommendation
Ivabradine
5 mg tablets Pack of 56
£12.53PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Can be initiated in primary care following specialist recommendation  Other Antianginal DrugsView BNF Article on 'Ivabradine'View SPC on 'Ivabradine'View PIL on 'Ivabradine'
Can be initiated in primary care following specialist recommendation
Ivabradine
2.5 mg tablets Pack of 56
£42.52PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Can be initiated in primary care following specialist recommendation  Other Antianginal DrugsView BNF Article on 'Ivabradine'View SPC on 'Ivabradine'View PIL on 'Ivabradine'
Can be initiated in primary care following specialist recommendation
Ranolazine (Ranexa)
375 mg tab Pack of 60
£47.32PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications. Other Antianginal Drugs
PCT FORMULARY STATUSSpecialist Initiated Drugs Other Antianginal Drugs
View BNF Article on 'Ranolazine'View SPC on 'Ranolazine'View PIL on 'Ranolazine'
Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications.
Ranolazine (Ranexa)
500 mg tab Pack of 60
£47.32PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications. Other Antianginal Drugs
PCT FORMULARY STATUSSpecialist Initiated Drugs Other Antianginal Drugs
View BNF Article on 'Ranolazine'View SPC on 'Ranolazine'View PIL on 'Ranolazine'
Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications.
Ranolazine (Ranexa)
750 mg tab Pack of 60
£47.32PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications. Other Antianginal Drugs
PCT FORMULARY STATUSSpecialist Initiated Drugs Other Antianginal Drugs
View BNF Article on 'Ranolazine'View SPC on 'Ranolazine'View PIL on 'Ranolazine'
Ranolazine, as a non formulary drug, has a limited place in the patient pathway for the management of stable angina. Ranolazine would be considered for patients already on beta-blocker and/or calcium channel blocker and then only if long acting nitrate, nicorandil and ivabradine are not suitable or ineffective. Hence ranolazine is to be considered a non-formulary drug that should be specialist initiated, and where transfer of prescribing to primary care requires the appropriate transfer of information on dosing, cautions (including interactions with commonly prescribed drugs), and contraindications.
Trimetazidine
35 MG MR Tablets Pack of 1
- PCT FORMULARY STATUS: Hospital Only Drugs Other Antianginal DrugsView BNF Article on 'Trimetazidine'View SPC on 'Trimetazidine'View PIL on 'Trimetazidine'

 
© Kernow Clinical Commissioning Group 2024 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS